logo
#

Latest news with #Yen9

Jefferies Sticks to Their Buy Rating for Otsuka Holdings Co (OTSKF)
Jefferies Sticks to Their Buy Rating for Otsuka Holdings Co (OTSKF)

Business Insider

time20-07-2025

  • Business
  • Business Insider

Jefferies Sticks to Their Buy Rating for Otsuka Holdings Co (OTSKF)

Jefferies analyst Stephen Barker maintained a Buy rating on Otsuka Holdings Co today and set a price target of Yen9,500.00. The company's shares closed last Tuesday at $44.40. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Barker covers the Healthcare sector, focusing on stocks such as Sumitomo Dainippon Pharma Co, Otsuka Holdings Co, and Astellas Pharma. According to TipRanks, Barker has an average return of 6.3% and a 48.57% success rate on recommended stocks. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Otsuka Holdings Co with a $60.62 average price target, implying a 36.53% upside from current levels. In a report released on July 15, J.P. Morgan also maintained a Buy rating on the stock with a Yen11,000.00 price target.

Citi Keeps Their Buy Rating on Fuji Electric Co (FELTF)
Citi Keeps Their Buy Rating on Fuji Electric Co (FELTF)

Business Insider

time12-07-2025

  • Business
  • Business Insider

Citi Keeps Their Buy Rating on Fuji Electric Co (FELTF)

In a report released today, Takero Fujiwara from Citi maintained a Buy rating on Fuji Electric Co, with a price target of Yen9,000.00. The company's shares closed last Wednesday at $45.43. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Fujiwara is a 3-star analyst with an average return of 13.0% and a 50.00% success rate. Currently, the analyst consensus on Fuji Electric Co is a Strong Buy with an average price target of $55.18, representing a 21.46% upside. In a report released on July 8, Macquarie also maintained a Buy rating on the stock with a Yen8,400.00 price target. Based on Fuji Electric Co's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $332.34 billion and a net profit of $36.83 billion. In comparison, last year the company earned a revenue of $343.55 billion and had a net profit of $38.1 billion

Jefferies downgrades SHIMAMURA Co (SHAOF) to a Hold
Jefferies downgrades SHIMAMURA Co (SHAOF) to a Hold

Business Insider

time28-06-2025

  • Business
  • Business Insider

Jefferies downgrades SHIMAMURA Co (SHAOF) to a Hold

Jefferies analyst Michael Allen downgraded SHIMAMURA Co (SHAOF – Research Report) to a Hold yesterday and set a price target of Yen10,000.00. The company's shares closed last Wednesday at $66.50. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter SHIMAMURA Co has an analyst consensus of Hold, with a price target consensus of $67.58, a 1.62% upside from current levels. In a report released on June 17, Morgan Stanley also maintained a Hold rating on the stock with a Yen9,300.00 price target. The company has a one-year high of $72.86 and a one-year low of $41.64. Currently, SHIMAMURA Co has an average volume of 746.

Morgan Stanley Sticks to Their Buy Rating for COSMOS Pharmaceutical Corporation (3349)
Morgan Stanley Sticks to Their Buy Rating for COSMOS Pharmaceutical Corporation (3349)

Business Insider

time20-06-2025

  • Business
  • Business Insider

Morgan Stanley Sticks to Their Buy Rating for COSMOS Pharmaceutical Corporation (3349)

In a report released today, Ai Furukawa from Morgan Stanley maintained a Buy rating on COSMOS Pharmaceutical Corporation (3349 – Research Report), with a price target of Yen10,400.00. The company's shares closed today at Yen9,062.00. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Furukawa is an analyst with an average return of -5.5% and a 60.00% success rate. Furukawa covers the Consumer Cyclical sector, focusing on stocks such as ABC-MART, Asics, and Isetan Mitsukoshi Holdings. Currently, the analyst consensus on COSMOS Pharmaceutical Corporation is a Hold with an average price target of Yen9,825.00, which is an 8.42% upside from current levels. In a report released on June 13, Citi also maintained a Buy rating on the stock with a Yen11,200.00 price target.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store